losartan has been researched along with Tuberculosis, Pulmonary in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ditiatkov, AE | 1 |
| Radzevich, AE | 1 |
| Tikhonov, VA | 1 |
| Zholnin, PA | 1 |
| Mal'gina, GV | 1 |
1 other study available for losartan and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
[Respiratory and renal functions and blood electrolytic composition in patients with pulmonary tuberculosis in the treatment of heart failure].
Topics: Adult; Anti-Arrhythmia Agents; Antitubercular Agents; Electrolytes; Female; Heart Failure; Humans; K | 2002 |